Morgan Stanley’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-178,806
| Closed | -$5.24M | – | 6817 |
|
|
2017
Q3 | $5.24M | Sell |
178,806
-96,745
| -35% | -$2.71M | ﹤0.01% | 2917 |
|
|
2017
Q2 | $7.23M | Buy |
275,551
+124,282
| +82% | +$3.06M | ﹤0.01% | 2470 |
|
|
2017
Q1 | $3.54M | Buy |
151,269
+30,407
| +25% | +$750K | ﹤0.01% | 3242 |
|
|
2016
Q4 | $3.04M | Buy |
120,862
+87,997
| +268% | +$2.22M | ﹤0.01% | 3522 |
|
|
2016
Q3 | $922K | Sell |
32,865
-198,262
| -86% | -$5.08M | ﹤0.01% | 4097 |
|
|
2016
Q2 | $5.7M | Buy |
231,127
+181,311
| +364% | +$4.5M | ﹤0.01% | 2492 |
|
|
2016
Q1 | $1.1M | Sell |
49,816
-145,666
| -75% | -$3.88M | ﹤0.01% | 3860 |
|
|
2015
Q4 | $6.84M | Buy |
195,482
+100,422
| +106% | +$3.15M | ﹤0.01% | 2358 |
|
|
2015
Q3 | $2.71M | Buy |
95,060
+78,000
| +457% | +$2.62M | ﹤0.01% | 3225 |
|
|
2015
Q2 | $568K | Sell |
17,060
-11,077
| -39% | -$340K | ﹤0.01% | 4628 |
|
|
2015
Q1 | $793K | Sell |
28,137
-50,966
| -64% | -$1.27M | ﹤0.01% | 4310 |
|
|
2014
Q4 | $1.64M | Buy |
79,103
+1,642
| +2% | +$39K | ﹤0.01% | 3731 |
|
|
2014
Q3 | $1.89M | Sell |
77,461
-6,181
| -7% | -$164K | ﹤0.01% | 3484 |
|
|
2014
Q2 | $2.39M | Buy |
83,642
+37,425
| +81% | +$1.04M | ﹤0.01% | 3341 |
|
|
2014
Q1 | $1.29M | Buy |
46,217
+23,682
| +105% | +$581K | ﹤0.01% | 3785 |
|
|
2013
Q4 | $484K | Sell |
22,535
-5,040
| -18% | -$91.6K | ﹤0.01% | 4472 |
|
|
2013
Q3 | $365K | Sell |
27,575
-61,732
| -69% | -$832K | ﹤0.01% | 4542 |
|
|
2013
Q2 | $1.24M | Buy |
+89,307
| New | +$1.27M | ﹤0.01% | 3539 |
|
Morgan Stanley's PMC Position: Q4 2017 in Review
Morgan Stanley sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 178,806 shares — an estimated $5.24M sold.
Morgan Stanley first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $7.23M in Q2 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Morgan Stanley reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Morgan Stanley sold 178,806 PharMerica Corporation shares in Q4 2017, an estimated $5.24M.
- Morgan Stanley first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Morgan Stanley's PharMerica Corporation position peaked at $7.23M in Q2 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.